Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Cognitive Dysfunction × Ashwagandha × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cognitive Dysfunction 1 Chemotherapy-Related Cognitive Impairment 1

Interventions

Memantine 2 lithium sulfate 1 lime 1 XENP 1595 1 Ramipril 1 Methylphenidate 1 Lithium 1 Infliximab 1 Ibuprofen 1 Exercise 1 Cannabidiol 1 Behavior Therapy 1 Aspirin 1 Ashwagandha 1 Anticonvulsants 1 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04092647 2023-06-15

Ashwagandha for Cognitive Dysfunction

Sutter Health

Phase 2 Unknown

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡